View |
Edit |
Public Title |
Trial ID |
Status |
Date of registration |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children |
0 |
Pending |
2023-04-11 |
View |
Edit |
Enhancing iron status of adolescent girls (10-19 years) through improved cooking method of pigeon pea (Cajanus cajan L.) |
0 |
Pending |
2023-10-07 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |
View |
Edit |
|
0 |
Pending |
2023-11-12 |